CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Shares Shorted: Short Interest Down 54.3% in October

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 1,339 shares, a decline of 54.3% from the September 30th total of 2,927 shares. Based on an average daily trading volume, of 4,208 shares, the short-interest ratio is currently 0.3 days.

CSPC Pharmaceutical Group Price Performance

Shares of CSPC Pharmaceutical Group stock remained flat at C$4.11 during trading on Friday. 699 shares of the stock were exchanged, compared to its average volume of 2,962. CSPC Pharmaceutical Group has a fifty-two week low of C$3.26 and a fifty-two week high of C$5.46. The stock has a fifty day moving average price of C$4.63 and a 200-day moving average price of C$4.45.

CSPC Pharmaceutical Group Company Profile

(Get Free Report)

CSPC Pharmaceutical Group is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. The company researches, develops, manufactures and distributes finished pharmaceutical products and active pharmaceutical ingredients, serving hospitals, pharmacies and other healthcare channels.

Its product portfolio includes medicines for neurological, cardiovascular, oncology, anti-infective and other therapeutic areas. CSPC is known for products such as butylphthalide, used in the treatment of ischemic stroke, as well as oncology medicines, injectable therapies and a range of generic drugs.

Further Reading

Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.